Proton magnetic resonance spectroscopy and intracranial tumours: Clinical perspectives

Andrea Falini, Giovanna Calabrese, Daniela Origgi, Susanna Lipari, Fabio Triulzi, Marco Losa, Giuseppe Scotti

Research output: Contribution to journalArticlepeer-review


Proton magnetic resonance spectroscopy ( 1H-MRS) was applied to characterize intracranial tumours of different hystological types. Seventy patients with intracranial neoplasms were studied before receiving surgery, radiotherapy or chemotherapy. All tumours were characterized by reduced or absent N-acetylaspartate and increased signal from choline-containing compounds. Distinctive patterns were observed only for primitive brain neo-plasms; high-grade gliomas were differentiated from low-grade ones by higher levels of choline-containing compounds. The metabolic aspects of metastatic lesions were similar to high-grade gliomas. These results, together with the limitations of 1H-MRS and future applications are reviewed.

Original languageEnglish
Pages (from-to)706-714
Number of pages9
JournalJournal of Neurology
Issue number10
Publication statusPublished - 1996


  • Brain metabolism
  • Brain tumours
  • Magnetic resonance spectroscopy

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology


Dive into the research topics of 'Proton magnetic resonance spectroscopy and intracranial tumours: Clinical perspectives'. Together they form a unique fingerprint.

Cite this